In Memoriam

Recently published articles about In Memoriam

JCP
In Memoriam: Terence A. Ketter, MD
In Memoriam

August 18, 2025

Eminent bipolar disorder researcher and clinician Terence A. Ketter, MD, is remembered.
,
JCP
In Memoriam: Robert M. A. Hirschfeld, MD
In Memoriam

March 20, 2023

Robert M. A. Hirschfeld is remembered as a pioneer in the phenomenology and treatment of bipolar disorder.
JCP
In Memoriam: Joseph Biederman, MD
In Memoriam

February 22, 2023

Colleagues and friends remember Joseph Biederman and reflect on his legacy as the father of pediatric psychopharmacology.
, , , et al
JCP
In Memoriam: Charles Bowden, MD, 1938–2022
In Memoriam

September 5, 2022

Over his long and distinguished career, Charles Bowden, MD, was a tireless advocate for bipolar disorder patients and an inspiration to colleagues. Trisha Suppes and Gary Sachs reflect on...
,
JCP
In Memoriam: Jan Fawcett, MD
In Memoriam

July 11, 2022

A. John Rush and Steven D. Hollon reflect on Fawcett’s life and his contributions to the field, especially in the areas of treatment-resistant depression and suicide.
,
JCP
In Memoriam

January 4, 2022

Aaron T. Beck, founding father of Cognitive Therapy, was ranked the fourth most influential person in the history of medicine in a 2016 survey. Colleague and friend Michael Thase...

Recent JCP Articles on In Memoriam

JCP
Evaluation of Sexual Function With Adjunctive Lumateperone in Major Depressive Disorder
Original Research

September 2, 2026

Adjunctive lumateperone 42 mg did not worsen sexual functioning and was not associated with treatment-related sexual dysfunction.
, , , et al
PCC
Intrusive PTSD Symptoms and Elevated CRP in World Trade Center Responders
Original Research

September 1, 2026

Intrusive PTSD symptoms may contribute to systemic inflammation in WTC responders, thus targeting both PTSD symptoms and obesity/dyslipidemia may help mitigate risk for elevated systemic inflammation.
, , , et al
JCP
Pharmacotherapies for Co-Occurring Stimulant Use Disorder and ADHD
Meta-Analysis

August 31, 2026

Stimulant-based pharmacotherapies, particularly higher-dose methylphenidate and mixed amphetamine salts, were associated with superior outcomes for both stimulant-use indicators and ADHD symptoms.
, , , et al

Recent PCC Articles on In Memoriam

JCP
Electroconvulsive Therapy and All-Cause, Nonsuicide, and Suicide Mortality
Clinical and Practical Psychopharmacology

August 31, 2026

Evidence on the association of ECT with lower risk of short- and long-term all-cause mortality, nonsuicide mortality, and suicide mortality is reviewed.
Improved but Not Recovered: The Relapsing Course of Generalized Anxiety Disorder
news

August 28, 2026

GAD follows a chronic, relapsing course in which comorbidity reduces recovery odds and antidepressant discontinuation roughly triples relapse risk.
Safety Across Classic Psychedelics in GAD: What Three Investigational Programs Show So Far
news

August 28, 2026

Early safety data from lysergide, psilocybin, and deuterated DMT GAD trials show predominantly mild-to-moderate, session-concentrated adverse events across all three programs.

Featured In Memoriam Research

PCC
Managing 7-hydroxymitragynine Withdrawal
Case Report

August 27, 2026

A 49-year-old man taking “7-OH” experienced significant opioid withdrawal symptoms that resolved with high-dose buprenorphine-naloxone treatment.
,
JCP
Obstetric Risk Associated with Stimulant vs Nonstimulant Treatment
Original Research

August 26, 2026

Stimulant and nonstimulant use during pregnancy were both associated with increased risk for obstetric complications vs no medication.
,
JCP
ADHD Medication Safety in Pregnancy: Precise Estimates, Uncertain Causal Inference
Commentary

August 26, 2026

Comments on a recent study by Babinski and Tuan finding ADHD medication use predictive of adverse pregnancy outcomes.
JCP
In Memoriam

October 13, 2020

S. Nassir Ghaemi reflects on the life and accomplishments of this founding pioneer of psychopharmacology.
JCP
In Memoriam

September 17, 2019

A reflection on the legacy and contributions of Donald F. Klein, a founding member of ASCP and pioneer in the modern era of psychiatry.
,
JCP
In Memoriam

March 23, 2016

Read about Lori Altshuler's life and how she effected psychiatry throughout her life.
JCP
In Memoriam

February 24, 2016

JCP
In Memoriam

April 15, 2012

JCP
In Memoriam

April 16, 2007

,

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe